维普中文期刊产品整合服务
14篇 您的检索式:作者名="PlassA"
    题名 作者 年代 出处 被引量
1TP53 status and response to treatment in breast cancers显示文摘Varna M Bousquet O Plassa L F 2011J Biomed biotechnol2011,2011,28:1
2Accuracy of MSCT coronary angiography with 64-slice technology: first experience显示文摘Leschka S Alkadhi H PlassA 2005Eur Heart J2005,26,15:1
3Effect of mutated TP53 on response of advanced breast cancers to high-dose chemotherapy显示文摘Bertheau P Plassa F Espie M 2002Lancet2002,360,9336:1
4TP53 Status and Response to Treatment in Breast Cancers显示文摘Mariana Varna Guilhem Bousquet Louis-Fran?ois Plassa Philippe Bertheau Anne Janin Paul W. Doetsch 2011Journal of Biomedicine and Biotechnology2011,,:1
5Effect of mutated TP53 on response of advanced breast cancers to high-dose chemotherapy 显示文摘BERTHEAU P PLASSA F ESPIE M 2002Lancet2002,360,9336:1
6TP53 status and response to treatment in breast cancers显示文摘Varna M Bousquet G Plassa LF 2011J Biomed Biotechnol2011,2011,28:1
7TP53 status and re- sponse to treatment in breast cancers显示文摘Varna M Bousquet G Plassa LF 2011J Biomed Biotechnol2011,20,:1
8Accuracy of dual-source CT coronary angiography:first experience in a high pretest probability population without heart rate control 显示文摘Scheffel H Alkadhi H PlassA 2006Eur Radiol2006,16,12:1
9Expression of C- terminal deleted p53 isoforms in neuroblastoma 显示文摘Goldsehneider D H orvilleur E Plassa LF 2006Nucleic Acids Res2006,34,19:1
10TP53 status and response to treatment in breast cancers显示文摘Vama M Bousquet G Plassa LF 2011J Biomed Biotechnol2011,20,11:1
11Accuracy of MSCT coronary angiography with 64-slice technology: first experience显示文摘LeschkaS Alkadhi H PlassA et aT 2011Eur Heart J2011,26,15:1
12Accuracy of dual - source CT coronary angiography: First experience in a high pre - test probability population without heart rate control 显示文摘Scheffel H Alkadhi H PlassA 2006Eur Radiol2006,16,12:1
13血管免疫母细胞性T细胞淋巴瘤患者血管内皮生长因子C表达的分析显示文摘目的探讨血管内皮生长因子 C(VEGF-C)在恶性淋巴瘤患者淋巴瘤组织中的表达及其与疾病进展的关系。方法运用实时定量 PCR 方法检测了81例恶性淋巴瘤患者淋巴瘤组织中VEGF-C 的表达。联合激光微切割技术和定量 PCR 法从淋巴瘤组织中特异性分离淋巴瘤细胞,检测淋巴瘤细胞中 VEGF-C 的表达。同时通过电镜对淋巴瘤组织切片中血管结构进行观察。结果与淋巴结反应性增生患者(8例)淋巴结的 VEGF-C 表达量(1.55±0.19)相比,血管免疫母细胞性 T 细胞淋巴瘤患者(18例)组织(15.35±9.07)和微切割的患者(10例)淋巴瘤细胞(15.19±4.28)均高表达VEGF-C(P 值分别为0.0020 和<0.01)。VEGF-C 高表达的患者常伴骨髓浸润(P=0.0039)和皮肤累及(P=0.0046),国际预后指数分组多为高危组(P=0.0302)。VEGF-C 高表达者存在血管结构异常,表现为血管内皮细胞肿胀,或缺乏周围细胞。结论 VEGF-C 表达与血管免疫母细胞性 T 细胞淋巴瘤的疾病进展密切相关。赵维莅 刘艳艳 Francois PLASSA 金晓龙 王黎 Anne JANIN 沈志祥 2007中华血液学杂志2007,28,10:0
14The cooperation between the Chinese Bureau of Fisheries and the Norwegian Directorate of fisheries显示文摘Lisbeth Plassa 2001海洋水产研究2001,22,4:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费